Issue #284
- Viral Immunology Advances Suggest Treatment Strategies
- New Meeting on Immune Surrogate Markers, Baltimore, January 9-11
- FDA Approves New Kind of Lymphoma Treatment
- Major AIDS Institute Inaugurated in San Francisco
- Protease Inhibitor Information: FDA Fact Sheet Available
- Protease Inhibitor Failure Trial: Combination 1592, 141W94, and Efavirenz
- New AIDS Bookstore on World Wide Web
- Revised Federal Antiretroviral Treatment Guidelines
- FDA Reform Signed into Law
- Press Must Register Now to Cover Feb. Retroviruses Meeting; Dec. 29 Deadline
- Correction: FORTOVASE(tm) Information Number for Patients in Wash. D.C. Area
- December Deadline for Charitable Giving and Tax Relief
source: AIDS Treatment News
